CD8A and neoplasm: Additionally, TAMs are involved in modulating the infiltration and function of CD8+ T cells.[15] Thus, identifying targets to alter the activation or reprogramming of TAMs into the M1 phenotype holds great potential for enhancing tumor immunotherapy.